BioConverGene Technologies Corporation
Generics
BioConverGene Technologies Corporation has sophisticated and extensive manufacturing facilities to produce market ready generic drugs.
Type II 5alpha-reductase inhibitor Androgenetic Alopecia Benign Prostatic Hyperplasia

Triptans Migraines and Cluster Headaches

Triazole Antifungal Drugs Systemic and Superficial Fungal Infections

Synthetic Nitrothiazolyl Derivatives Anti-protozoal Agents

Serotonin 5-HT3 Receptor Antagonists Antiemetic Agents

Semisynthetic Tetracycline Antibiotics

Selective Serotonin Reuptake Inhibitors (SSRI) Antidepressants and Related Disorders
 Antidepressants and Related Disorders/Fluoxetine.png)
 Antidepressants and Related Disorders/Paroxetine.png)
Second Generation Fluoroquinolone Antibiotics


Second Generation Anti-histamines Treatment of Allergies

Phenethylamine Psychostimulant Drugs Appetite Suppressants

Pancreatic Lipases Inhibitor Anti-obesity Agents

Osteoporosis and Bone Diseases


Non-steroidal Anti-Inflammatory Drugs (NSAID)
/Aceclofenac.png)
/Naproxen Paracetamol.png)
Muscarinic Antagonists Antiemetics Antivertigo

Macrolide Antibiotics

Lincosamide Antibiotics Antriprotozoal-Antimalaria Agents Acne MRSA Infections

Immuno-supressants Transplant Homeostasis


Hyperuricemia Chronic Gout

Heterocyclic Acitic Acid Derivatives Analgesics Non-steroidal Anti-Inflammatory Drugs


First Generation Synthetic Fluoroquinolone Antibacterial Agents

Calcium Channel Blockers-Antihistmine Cerebral Apoplexy and Motion Sickness Agents

Calcium Channel Blockers Anti-hypertensive Compounds


Biguanide Type II Antidiabetic Drugs


Antiemetic Gastroprokinetic Agents Nausea Gastroesophageal Reflux Disorders

Angiotensin Converting Enzyme Inhibitors Anti-hypertensives




Alpha 1a Selective Alpha Blockers Symptomatic Benign Prostatic Hyperplasia
